Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia

Venetoclax is used for the priority treatment of elderly patients with acute myeloid leukemia (AML). Resistance or intolerance to venetoclax offsets its clinical benefits in some patients. Combination strategies with other drugs are promising alternatives to overcome the current complications associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Cheng, Wang, Zhiqin, Yang, Shuanghui, Li, Huan, Zhao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277771/
https://www.ncbi.nlm.nih.gov/pubmed/35847946
http://dx.doi.org/10.3389/fonc.2022.864430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277771/
https://www.ncbi.nlm.nih.gov/pubmed/35847946
http://dx.doi.org/10.3389/fonc.2022.864430

Ejemplares similares